https://jpnim.com/index.php/jpnim/issue/feed Journal of Pediatric and Neonatal Individualized Medicine (JPNIM) 2022-06-21T12:47:36+02:00 JPNIM Staff journal@jpnim.com Open Journal Systems <p>The <strong>Journal of Pediatric and Neonatal Individualized Medicine (JPNIM)</strong> is a peer-reviewed interdisciplinary journal which provides a forum on new perspectives in pediatric and neonatal medicine. The aim is to discuss and to bring readers up to date on the latest in research and clinical pediatrics and neonatology. Special emphasis is on developmental origin of health and disease or perinatal programming and on the so-called ‘-omic’ sciences. Systems medicine blazes a revolutionary trail from reductionist to holistic medicine, from descriptive medicine to predictive medicine, from an epidemiological perspective to a personalized approach. The journal will be relevance to clinicians and researchers concerned with personalized care for the newborn and child. Also medical humanities will be considered in a tailored way.</p> <p>Article submission (original research, review papers, invited editorials and clinical cases) will be considered in the following fields: fetal medicine, perinatology, neonatology, pediatrics, developmental programming, psychology and medical humanities.</p> https://jpnim.com/index.php/jpnim/article/view/e110220 Lectures of the School of Advanced Training on the Pediatric Microbiota [Scuola di Alta Formazione sul Microbiota in Età Pediatrica]; webinar; February-March 2022 2022-06-21T12:47:36+02:00 --- Various Authors journal@jpnim.com <p class="p1"><strong>Lectures of the School of Advanced Training on the Pediatric Microbiota</strong><span class="s1"><strong> [Scuola di Alta Formazione sul Microbiota in Età Pediatrica]</strong></span></p> <p><strong>An all-around view of the microbiota for clinical pediatric practice [Il microbiota a 360 gradi per la pratica clinica pediatrica]</strong></p> <p class="p3"><span class="s3"><strong>Webinar • February-March 2022</strong></span></p> <p class="p4">&nbsp;</p> <p class="p5">The meeting has been organized with the unconditional contribution of BROMATECH.</p> <p class="p5">&nbsp;</p> <p class="p1"><strong>LECT 1. THE SCHOOL OF ADVANCED TRAINING ON THE PEDIATRIC MICROBIOTA [LA SCUOLA DI ALTA FORMAZIONE SUL MICROBIOTA IN ETÀ PEDIATRICA]</strong> • V. Fanos, M. Romeo (Cagliari and Pavia, Italy)<span class="Apple-converted-space">&nbsp;</span></p> <p class="p1"><strong>LECT 2. YOU WILL NEVER FORGET YOUR FIRST MICROBIOTA [IL PRIMO MICROBIOTA NON SI SCORDA MAI]</strong> • V. Fanos (Cagliari, Italy)</p> <p class="p1"><strong>LECT 3. BREASTFEEDING, WEANING AND HEALTHY GROWTH OF THE BABY [ALLATTAMENTO, SVEZZAMENTO E CRESCITA SANA DEL BAMBINO]</strong> • D.G. Peroni (Pisa, Italy)</p> <p class="p1"><strong>LECT 4. THE ROLE OF GUT MICROBIOTA AND PROBIOTICS SUPPLEMENTATION IN THE MANAGEMENT OF INFANTILE COLIC [IL RUOLO DEL MICROBIOTA INTESTINALE E DELL’INTEGRAZIONE PROBIOTICA NELLA GESTIONE DELLE COLICHE INFANTILI]</strong> • M. Romeo (Pavia, Italy)</p> <p class="p1"><strong>LECT 5. A JOURNEY INTO THE MICROBIOTA AMONG ALLERGIES AND IMMUNE SYSTEM DISEASES [VIAGGIO NEL MICROBIOTA TRA ALLERGIE E MALATTIE DEL SISTEMA IMMUNITARIO]</strong> • R. Castagnoli, G.L. Marseglia (Pavia, Italy)</p> <p class="p1"><strong>LECT 6. WHAT IS EVIDENT IN METABOLIC DISORDERS: OBESITY, DIABETES AND MICROBIOTA [EVIDENZE NEI DISORDINI METABOLICI: OBESITÀ, DIABETE E MICROBIOTA]</strong> • G. Banderali (Milan, Italy)</p> <p class="p1"><strong>LECT 7. THE KNOWLEDGE OF THE MICROBIOTA IN PRIMARY CARE [I RISVOLTI PRATICI DELLE CONOSCENZE SUL MICROBIOTA]</strong> • G. Trapani, G. Maiocco, A. Spadavecchia (Sanremo and Turin, Italy)</p> <p class="p1"><strong>LECT 8. MICROBIOTA AND NUTRITION IN PEDIATRIC AGE [MICROBIOTA E NUTRIZIONE IN ETÀ PEDIATRICA]</strong> • L. Emma (Turin, Italy)</p> <p class="p1"><strong>LECT 9. THE MUCO-MICROBIOTIC LAYER: THE INNERMOST COMPONENT OF THE BOWEL WALL [LO STRATO MUCO-MICROBIOTICO: LA COMPONENTE PIÙ INTERNA DELLA PARETE INTESTINALE]</strong> • F. Cappello (Palermo, Italy)</p> <p class="p1"><strong>LECT 10. PROBIOTICS ARE NOT ALL THE SAME [I PROBIOTICI NON SONO TUTTI UGUALI]</strong> • R. Francavilla, F. Cristofori (Bari, Italy)</p> <p class="p1"><strong>LECT 11. IS THERE A MICROBIOME SIGNATURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE? [VI È UN MICROBIOMA INTESTINALE SPECIFICO NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI PEDIATRICHE?]</strong> • M. Martinelli, A. Staiano (Naples, Italy)</p> <p class="p1"><strong>LECT 12. MICROBIOTA AND NEURODEVELOPMENT [MICROBIOTA E NEUROSVILUPPO]</strong> • P. Rossi (Pavia, Itay)</p> <p class="p1"><strong>LECT 13. MICROBIOMICS AND METABOLOMICS IN AUTISM SPECTRUM DISORDER [MICROBIOMICA, METABOLOMICA E DISTURBI DELLO SPETTRO AUTISTICO]</strong> • M. Mussap (Cagliari, Italy)</p> <p class="p1"><strong>LECT 14. WHAT FUTURE FOR HUMAN HEALTH? [QUALE FUTURO PER LA SALUTE UMANA?]</strong> • A. Maglioni (Civitella di Romagna, Italy)</p> <p class="p5">&nbsp;</p> <p class="p5">&nbsp;</p> 2022-06-21T00:00:00+02:00 Copyright (c) 2022 © Hygeia Press https://jpnim.com/index.php/jpnim/article/view/e110222 Saffron for mood improvement in children and adolescents: a narrative review 2022-04-24T11:58:00+02:00 Gianfranco Trapani gianfranco@trapanigianfranco.it Giulia Maiocco giulia.maiocco@unito.it Alessia Spadavecchia alessia.spadavecc@edu.unito.it <p class="p1">Depressive and anxious disorders could be experienced by children and adolescents worldwide and are associated with psychiatric syndromes diagnosed in adulthood. In this context, the COVID-19 outbreak and digital media arising use have worsened mental conditions in the pediatric population. Older adolescents, girls, and patients living with neurodiversity and/or chronic physical conditions are more likely to develop negative mental health outcomes. </p> <p class="p1"><em>Crocus sativus L.</em> (saffron) is a medicinal plant whose most biologically relevant components are two carotenoids (crocin and crocetin) and two apocarotenoids (picrocrocin and safranal). Crocin seems to inhibit the uptake of dopamine and norepinephrine, while safranal inhibits the serotonin reuptake; in vitro and in animal models, crocin also displayed neuroprotective abilities, increasing the intracellular levels of neurotrophic factors. Further studies are required to strengthen these results; however, multiple studies have already demonstrated significant positive effects of saffron on psychiatric disorders – including depression and anxiety in young patients. Saffron administration appears to reduce depression symptoms and to strengthen antidepressant effects of current drugs (fluoxetine), also lowering adverse events of these therapies. Consequently, saffron could have an important role as a complementary therapy for depressive and anxious disorders in children and teenagers.</p> 2022-06-27T00:00:00+02:00 Copyright (c) 2022 © Hygeia Press https://jpnim.com/index.php/jpnim/article/view/e110219 Allergic rhinitis in children in pneumo-allergology consultation at the Teaching Hospital Campus of Lomé (Togo) 2021-03-04T23:31:02+01:00 Mawouto Fiawoo michaelisfirst@yahoo.fr Nadiedjoa Kokou Douti lucdouti2009@yahoo.fr Manani Hemou mhemou@yahoo.fr Koko Lawson-Evi annettelawson2001@yahoo.fr Kokoe Bénédicte Kangni benedictekangni@gmail.com Mananté Kamaga houedjean@yahoo.fr Dzayisse Yawo Atakouma yatakouma@yahoo.fr <p class="p1"><span class="s1"><strong>Background:</strong> Allergic rhinitis (AR) is one of the most common chronic pathologies in children. The objective of this study was to determine the prevalence of AR in children undergoing pneumo-allergology consultation at the Teaching Hospital Campus of Lomé (Togo). </span></p> <p class="p1"><span class="s1"><strong>Methods:</strong> A cross-sectional study was carried out in the Pneumo-Allergology Unit of the Teaching Hospital Campus of Lomé from January 1, 2018, to December 31, 2019. We included in our study all children (0 to 18 years old) who consulted in our Unit. The parameters studied included demographic and clinical data, home environment (external and internal of the concessions and internal environment of the rooms), total IgE test, results of skin prick tests, and diagnosis. </span></p> <p class="p1"><span class="s2"><strong>Results:</strong> We identified a total of 179 cases of AR (19 of which were excluded) out of 380 children who had consulted during our study period; the prevalence was 47.11%. Children aged 0 to 5 years accounted for 57.50% of patients. There was male dominance, with a sex ratio of 1.5. Clear rhinorrhoea was the symptom found in 100% of cases, followed by sneezing (85.63%) and nasal obstruction (85.00%). Asthma was frequently associated (47.37%). </span>Rhinopharyngitis accounted for 59.86% of the allergic pathologies identified in the families, followed by asthma (34.51%)<span class="s2">. The house was old (&gt; 10 years) in 58.75%, the mattress was old (&gt; 5 years) in 44.38%, and the pillow was old (&gt; 5 years) in 44.22% of cases. </span>The majority (55.63%) of patients had pets in the home, and the predominant pet was the cat (67.42%)<span class="s2">. The skin prick test, carried out in 110 patients, had noted sensitization to dust mites (100%), cat dander (58.18%), cockroaches (58.18%) and molds (28.18%). AR was persistent in 60.63% of cases. Sneezing was more common in moderate to severe persistent AR than in mild persistent AR (p &lt; 0.0001).<span class="Apple-converted-space"> </span></span></p> <p class="p1"><span class="s1"><strong>Conclusion:</strong> The prevalence of AR in children was high. Persistent AR was the most common.</span></p> 2022-06-21T00:00:00+02:00 Copyright (c) 2022 © Hygeia Press https://jpnim.com/index.php/jpnim/article/view/e110214 Correspondence: do not overlook parental grief following an infant death in the Neonatal Intensive Care Unit 2021-05-09T12:40:19+02:00 Hüseyin Çaksen huseyincaksen@hotmail.com <p class="p1"><span class="s1">Parents’ bereavement results in high rates of psychological, emotional, physiological, and existential distress after the death of a child during pregnancy, at delivery or in the neonatal period. Parental grief following an infant’s death is usually neglected or overlooked in many Neonatal Intensive Care Units in both developed and developing countries. </span></p> <p class="p1"><span class="s1">We report our observations about grieving parents in order to increase the awareness of health professionals regarding the importance of grief for the death of their infant.</span></p> <p class="p1"><span class="s1">In conclusion, in </span><span class="s1">this report, we would like to emphasize that grieving parents following a perinatal death should be supported not only physically, but also psychosocially and spiritually by health professionals.<span class="Apple-converted-space"> </span></span></p> 2022-06-21T00:00:00+02:00 Copyright (c) 2022 © Hygeia Press